|
The Seventh Annual Hematology Symposium will feature regional forum on education on emerging and established treatment options in hematology. This course seeks to bridge the gap between large national or international conferences and the convenience of a smaller educational forum which can facilitate local and regional collaborations in healthcare.
This activity was developed for primary care physicians, nurses, nurse practitioners, physician assistants, and other professionals with an interest in hematology.
As a result of attending this course, I am better able to:
- Recognize and treat thalassemia
- Identify patients with bleeding or clotting disorders for whom the expert referral is needed
- Discuss strategies to minimize the use of blood components
- Diagnose and manage COVID-19 in the immunocompromised host
- Understand emerging treatment options for autoimmune disorders with hematologic implications
- Treat or refer patients with diffuse large B-Cell Lymphoma
- Discuss emerging applications for CAR-T cell therapy and other cellular therapy options
In order to account for attendance and receive CME credit for participating through Zoom, please click on this link and complete the evaluation.
Evaluation links will close on Sunday, October 30, 2022 at 11:00pm
For more information, please contact Elizabeth Yi at elizyi@hs.uci.edu or Alex Fernandez at aaferna3@hs.uci.edu
Full disclosure information from all those in control of content will be provided in advance of the activity.
Accreditation Statement
The University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The University of California, Irvine School of Medicine designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All of the course directors, planners, speakers, moderators, and peer reviewers have nothing to disclose, except those shown below.
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California, Irvine School of Medicine.
All conflicts have been mitigated in advance.